When was Karius founded?

Karius was founded in 2014 and raised its 1st funding round 2 years after it was founded.

Where is Karius located?

Karius is headquartered in Redwood City, United States. It is registered at Redwood City, California.

How many employees does Karius have?

As of Jun 30, 2026, the latest employee count at Karius is 212.

Is Karius a funded company?

Karius is a funded company, having raised a total of $315M across 5 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Sep 20, 2016.

How much is Karius worth?

The latest valuation of Karius is $***** as of Feb 24, 2020.

When was the latest funding round of Karius?

Karius' latest funding was a $***** Series C round on May 02, 2024, with participation from 10 investors.

Where does Karius rank among its competitors?

Karius ranks 10th amongst 429 active competitors, of which 102 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was Daye, which secured $576K in Nov, 2025.

Who are the top competitors of Karius?

Karius' top competitors include Adaptive Biotechnologies, MeMed and OpGen. Among them, Daye secured the most recent funding round in November, 2025.

Karius - 2026 Company Profile, Team, Funding & Competitors

Company Details

Provider of diagnostics for identifying infectious diseases using microbial DNA. It offers Karius Test that uses clinical metagenomics specifically microbial cell-free DNA, or mcfDNA plus AI and sequencing to detect pathogens such as bacteria, fungi, viruses, parasites in the body from non-invasive samples.

Website: kariusdx.com
Social
Email ID: *****@kariusdx.com
Phone Number: +1 **********
Registered Address: Redwood City, California

Key Metrics

Founded Year

2014

Location

Redwood City, United States

Stage

Series C

Total Funding

$315M in 5 rounds

Latest Funding Round

Series C, May 02, 2024, $*****

Post Money Valuation

$***** as on Feb 24, 2020

Investors

Khosla Ventures & 17 more

Ranked

10^th among 429 active competitors

Employee Count

212 as on Jun 30, 2026

Similar Companies

OpenEvidence & 2857 more

View Karius' full profile

Karius is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Karius, Inc. CIN: 471779950 , United States, Active	Aug 26, 2014	-	177 (As on Dec 31, 2024)	-

Karius has raised a total funding of $315M over 5 rounds. Its first funding round was on Sep 20, 2016. Its latest funding round was a Series C round on May 02, 2024 for $*****. 10 investors participated in its latest round. Karius has 18 institutional investors.

Here is the list of recent funding rounds of Karius:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
May 02, 2024	2061675	Series C	4053206	9905304	5302870	2589089
Feb 24, 2020	6616252	Series B	5654262	9476925	8002706	General Catalyst & 3 more
Nov 29, 2018	4369826	Conventional Debt	1067388	6582197	3555348	Oxford Finance

Access funding benchmarks and valuations. Sign up today!

View details of Karius's funding rounds and investors

Karius' employee count trend

Karius has 212 employees as of Jun 26. Here is Karius's employee count trend over the years:

Uncover Karius' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Karius include Adaptive Biotechnologies, MeMed and OpGen. Here is the list of Top 10 competitors of Karius, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Adaptive Biotechnologies 2009, Seattle (United States), Public	Provider of clinical diagnostics, and drug discovery for immune diseases	$419M	Viking Global Investors, Matrix & 21 others	77/100
2nd	MeMed 2009, Tirat Carmel (Israel), Series D	Provider of machine learning based diagnostic solutions for infectious diseases	$163M	La Maison Partners, Ping An & 23 others	69/100
3rd	OpGen 2002, Rockville (United States), Public	Developer of diagnostics and bioinformatics platforms for providers	$77.5M	Cross Creek, 180 Degree Capital & 12 others	67/100
4th	HaystackAnalytics 2018, Mumbai (India), Seed	Provider of genomics technology for personalized clinical decisions	$17.3M	STRIVE, Sun Pharma & 32 others	67/100
5th	NeuroKaire 2017, Kearny (United States), Series A	Platform offering personalized treatment for psychiatric and neurological conditions	$20M	GreyBird Ventures, Meron Capital & 6 others	62/100
6th	Sophia Genetics 2011, Rolle (Switzerland), Public	Provider of artificial intelligence software for analyzing complex medical data	$249M	Generation Investment Management, Endeavour Vision ... & 24 others	62/100
7th	Daye 2018, London (United Kingdom), Series A	Manufacturer of period care products and provider of health tests	$19.2M	Khosla Ventures, Salica Investments & 24 others	60/100
8th	Huwel Life 2015, Hyderabad (India), Series A	Molecular diagnostic solutions and products for the healthcare industry	$5.74M	Bartronics, BIRAC & 3 others	59/100
9th	Oncimmune 2006, Cambridge (United States), Acquired	Immunodiagnostics company developing biomarker platforms for cancer and immune diseases	-	IPF Partners, Balderton Capital & 9 others	58/100
10th	Karius 2014, Redwood City (United States), Series C	Provider of diagnostics for identifying infectious diseases using microbial DNA	$315M	Gilde Healthcare, HBM Healthcare Investments ... & 16 others	58/100